7 Enzymes involved in triglyceride hydrolysis

Bailliere's Clinical Endocrinology and Metabolism

Volumn 1, Issue 3, 1987, Pages 639-666

  Taskinen, Marja Riitta ^a   Kuusi, Timo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

HUMAN; HYDROLYSIS; LIPOPROTEIN METABOLISM; LIVER; REVIEW;

ANIMAL; CHYLOMICRONS; HUMAN; HYDROLYSIS; LIPOLYSIS; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; LIVER; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0023639149     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(87)80027-7     Document Type: Article

References (159)

1. Lipoprotein abnormalities in patients with early primary biliary cirrhosis
2. 2 cholesterol
3. Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver
4. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients
5. A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase
6. 61 in human apolipoprotein C-II does not alter its activation of lipoprotein lipase
7. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells
8. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture
9. Plasma lipoprotein changes resulting from immunologically blocked lipolysis
10. The hepatic heparin releasable lipase binds to high density lipoproteins
11. Evidence for independent genetic regulation of heart and adipose lipoprotein lipase activity
12. Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities
13. Plasma decay of chylomicron remnants is not affected by heparin-stimulated plasma lipolytic activity in normal fasting man
14. Dynamics of apolipoprotein E metabolism in humans
15. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins
16. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II
17. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase
18. Heterogeneity of primary lipoprotein lipase deficiency
19. Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency
20. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias
21. Lipoprotein lipase secretion by human monocyte-derived macrophages
22. Importance of the different steps of glycosylation for the activity and secretion of lipoprotein lipase in rat preadipocytes studied with monensin and tunicamycin
23. Purification and characterization of human lipoprotein lipase and hepatic triglyceride lipase
24. Enzyme-linked immunosorbent assay for rat hepatic triglyceride lipase
25. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism
26. Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase
27. Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3
28. Lipoprotein lipase hydrolysis of trioleoylglycerol in a phospholipid interface
29. 2 during the action of LCAT: the role of triglyceride-rich lipoproteins
30. Intracellular processing of hepatic lipase
31. Lipoprotein lipase is produced, regulated, and functional in rat brain
32. The publication of a lipoprotein lipase from bovine skim milk
33. Preparation, characterization and measurement of hepatic lipase
34. Heterogeneity of salt-resistant lipase from human postheparin plasma
35. Two methods compared for measuring lipase activity in plasma after heparin administration
36. High density lipoprotein metabolism
37. Plasma lipoprotein conversions
38. Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue
39. La lipoprotéine lipase
40. Familial lipoprotein lipase and apolipoprotein C-II deficiency
41. Lipolytic activity of postheparin plasma in hyperglyceridemia
42. Hepatic triglyceride lipase deficiency in liver disease
43. Purification of canine postheparin hepatic lipase
44. Monoclonal antibodies to avian lipoprotein lipase. Purification of the enzyme by immunoaffinity chromatography
45. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI
46. The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease
47. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey
48. Plasma lipoprotein abnormalities associated with acquired hepatic triglyceride lipase deficiency
49. Immunologic and enzymatic comparisons between human and bovine lipoprotein lipase
50. VLDL catabolism in the lipoprotein lipase (LPL) deficient monkey: evidence for an essential role of LPL in LDL production
51. Production and use of an inhibitory monoclonal antibody to human lipoprotein lipase
52. Purification of a human postheparin plasma triglyceride lipase
53. Selective degradation of the high density lipoprotein-2 subfraction by heparin-releasable liver lipase
54. Liver lipase and high-density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase
55. Function of hepatic triglyceride lipase in lipoprotein metabolism
56. Chylomicron clearance in normal and hyperlipidemic man
57. Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat
58. Transport and metabolism of chylomicrons
59. Idiopathic hyperlipemia: metabolic studies in an affected family
60. Chylomicron and very low density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia
61. Serum-stimulated lipases (lipoprotein lipases). Immunological crossreaction between the bovine and the human enzymes
62. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III
63. 2, 1.045
64. Binding of chylomicron remnants and very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors
65. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma
66. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism
67. Familial hyper-alpha-lipoproteinemia with decreased hepatic triglyceride lipase deficiency
68. Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme
69. Lipoprotein lipase from bovine milk
70. Preparation, characterization, and measurement of lipoprotein lipase
71. Lipoprotein lipase-catalyzed hydrolysis of phospholipid monolayers: effect of fatty acyl composition on enzyme activity
72. Comparison of the triacylglycerol hydrolase activity of human post-heparin plasma lipoprotein lipase and hepatic triacylglycerol lipase. A monolayer study
73. Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase
74. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II
75. On the metabolic function of heparin-releasable liver lipase
76. Triacylglycerol lipase, monoacylglycerol lipase and phospholipase activities of highly purified rat hepatic lipase
77. Inhibition of human and rat lipoprotein lipase by high-density lipoprotein
78. Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia
79. Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II
80. Lipoprotein lipase and hepatic endothelial lipase: their roles in plasma lipoprotein metabolism
81. Cloning of rat hepatic lipase cDNA: evidence for a lipase gene family
82. Clearing factor, a heparin-activated lipoprotein lipase II substrate specificity and activation of coconut oil
83. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia
84. Mechanism of inhibition of hepatic triglyceride lipases from human postheparin plasma by apolipoproteins A-I and A-II
85. Heparin-releasable lipase of rat liver. Purification of the enzyme and studies on its function in lipoprotein metabolism
86. Modification of the substrate specificity of rat hepatic lipase by collagenase treatment
87. Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivo
88. Localization of the heparin-releasable lipase in situ in the rat liver
89. 2 in man
90. Human postheparin plasma hepatic lipase activity against triacylglycerol and phospholipid substrates
91. Function of hepatic endothelial lipase in lipoprotein metabolism
92. High density lipoprotein abnormalities in familial hepatic lipase deficiency and their reversal by treatment with an anabolic steroid (stanazolol)
93. Hydrolysis of lipid monolayers and the substrate specificity of hepatic lipase
94. Method of determining lipoprotein lipase activity in human adipose tissue
95. Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states
96. Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men
97. Effects of C apoproteins on the activity of endothelium-bound lipoprotein lipase
98. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity
99. Preparation and properties of immobilized lipoprotein lipase
100. Changes in high density lipoprotein subfractions during alimentary lipaemia
101. Mechanism of action of lipoprotein lipase
102. Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion
103. Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats
104. Lipoprotein lipase in human adipose tissue
105. Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man
106. Metabolic and endocrine control of plasma high density lipoprotein concentration
107. Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism
108. HDL in relation to the metabolism of triglyceride-rich lipoproteins
109. Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man
110. Role of lipoprotein lipase and hepatic endothelial lipase in the metabolism of high density lipoproteins: A novel concept on cholesterol transport in HDL cycle
111. Regulation of lipoprotein metabolism by endothelial lipolytic enzymes
112. Lipolytic enzymes and plasma lipoprotein metabolism
113. The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein—postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals
114. Lipoprotein lipase: an attempt to correlate its molecular properties to its function
115. The lipoprotein lipase system
116. Molecular size of bovine lipoprotein lipase as determined by radiation inactivation
117. Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells
118. Properties of salt-resistant lipase and lipoprotein lipase purified from human post-heparin plasma
119. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia
120. 3 by hepatic lipase
121. Immunocytochemical localization of the functional fraction of lipoprotein lipase in the perfused heart
122. A study of different methods for the assay of lipoprotein lipase activity in human adipose tissue
123. Human adipose tissue lipoprotein lipase: comparison of assay methods and expressions of activity
124. Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism
125. Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man
126. Roles of lipoprotein lipase and hepatic triglyceride lipase in the catabolism in vivo of triglyceride-rich lipoproteins
127. The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteins
128. Isolation of an active-site peptide of lipoprotein lipase from bovine milk and determination of its amino acid sequence
129. Effect of heparin-induced lipolysis on the distribution of apolipoprotein E among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase
130. Relationship between lipoproteins including HDL subfractions and the intravenous fat tolerance test
131. Hepatic lipase and lipoprotein lipase in postheparin plasma in liver disease. Relations to plasma proteins
132. Lipogenesis and lipoprotein lipase in human adipose tissue: reproducibility of measurements and relationships with fat cell size
133. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females
134. 2-triacylglycerols
135. 2-phospholipids and triglycerides by hepatic lipase
136. Post-heparin plasma hepatic triacylglycerol lipase-catalyzed tributyrin hydrolysis
137. Monoclonal antibodies to bovine milk lipoprotein lipase
138. Degradation of lipoprotein lipase in rat adipose tissue
139. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans
140. Lipoprotein Lipase in Human Adipose Tissue.
141. Effect of desialylation of very low-density lipoproteins on their catabolism by lipoprotein lipase
142. High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity
143. 3 levels by lipoprotein lipase
144. A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle
145. Alcohol-induced changes in serum lipoproteins and in their metabolism
146. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel
147. Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen
148. Hepatic lipase. Purification and characterization
149. Molecular mechanisms of action and activation of lipoprotein lipase
150. Action of lipoprotein lipase on phospholipid monolayers. Activation by apolipoprotein C-II
151. Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism
152. Lipoprotein lipase in cultured pig aortic smooth muscle cells
153. Maturation and secretion of lipoprotein lipase in cultured adipose cells. I. Intracellular activation of the enzyme
154. Monoclonal antibodies against bovine milk lipoprotein lipase. Characterization of an antibody specific for the apolipoprotein C-II binding site
155. Characterization of rat adipose tissue lipoprotein lipase using a monospecific antibody
156. Studies on the degradation of human very low density lipoproteins by human milk lipoprotein lipase
157. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III
158. Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency
159. Human lipoprotein lipase complimentary DNA sequence